May 28, 2020
First Light Diagnostics Names New Chief Financial Officer
May 19, 2020
Dr. David Shulkin Named to SmartSteward(TM) Board of Directors
May 11, 2020
3PRE Technology Brings Advancements In Antimicrobial Safety To Medical Device Industry
Apr 27, 2020
Thermo Fisher Scientific adds Cefiderocol and Imipenem/Relebactam to manual and automated Antimicrobial Susceptibility Testing Platforms including ARIS HiQ
Apr 14, 2020
Bausch + Lomb Announces Publication Of 10-Year Armor Study Results On Ocular Antibiotic Resistance In JAMA Ophthalmology
Feb 19, 2020
Multi-Drug-Resistant (MDR) Neisseria Gonorrhoeae - Pipeline Insight, 2020
Feb 12, 2020
FDA Grants Plasmology4® "Breakthrough Device Designation" for the Treatment of Multidrug-Refractory Bacteria
Jan 30, 2020
The Antimicrobial Crisis: New Antibiotics Could Avert 230,000 Deaths Per Year
Jan 08, 2020
Adaptive Phage Therapeutics Awarded Initial Contract with Department of Defense
Oct 31, 2019
Armata Pharmaceuticals Issues Letter to Shareholders
Oct 23, 2019
Biomica to Collaborate With Weizmann Institute of Science to Develop a Selective Treatment Against Antibiotic Resistant Bacteria
Oct 22, 2019
Qpex Biopharma and Brii Biosciences Enter Into a Strategic Collaboration to Develop and Commercialize Antibiotics for Drug-Resistant Infections in China
Sep 12, 2019
Armata Pharmaceuticals Announces Development of New Synthetic Phage Candidate Targeting Pseudomonas aeruginosa
Aug 14, 2019
FDA Approves Breakthrough Drug to Treat Extensively Drug-Resistant Tuberculosis
Aug 07, 2019
Carb-X to Expand Funding of Specific Diagnostics to Support the Development of a Rapid Antibiotic Susceptibility Test to Treat Life-Threatening Blood Infections
Aug 01, 2019
Prokaryotics Receives $2.3 Million SBIR Award Supporting Its Immune Potentiation Program and Advances Two Additional SBIR-funded Antibiotic Programs into Phase 2 Lead Optimization
Jul 10, 2019
Introducing Three New Formats for Antimicrobial Susceptibility Testing, Including New Compounds for Combatting Gram Negative and Multidrug-Resistant Infections
Jun 18, 2019
Armata Pharmaceuticals to Host Key Opinion Leader Meeting on Bacteriophage-Based Therapeutics on June 26 in New York
Jun 13, 2019
China National Medical Products Administration Approves Sinovant's Clinical Trial Application for Lefamulin
Jun 04, 2019
PDI Unveils Upcoming Advancements to Innovative Infection Prevention Product Line